CIK 1582844
ACUTA CAPITAL PARTNERS, LLC
Institutional 13F holdings & portfolio
Holdings
28
Portfolio Value
$1M+
Latest Report
Jun 30, 2025
Report Periods
1
Holdings
13F filings as of Jun 30, 2025 · Showing 1–28 of 28
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX INC | 1.0M | $1M+ | SH |
| CDTX | CIDARA THERAPEUTICS INC | 180K | $1M+ | SH |
| WHWK | WHITEHAWK THERAPEUTICS INC | 3.4M | $1M+ | SH |
| SLNO | SOLENO THERAPEUTICS INC | 63K | $1M+ | SH |
| TRML | TOURMALINE BIO INC | 284K | $1M+ | SH |
| ASND | ASCENDIS PHA-ADR | 23K | $1M+ | SH |
| INSM | INSMED INC | 37K | $1M+ | SH |
| ARGX | ARGEN SE - ADR | 7K | $1M+ | SH |
| PRAX | PRAXIS PRECISION MEDICINES I | 74K | $1M+ | SH |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 26K | $1M+ | SH |
| TRVI | TREVI THERAPEUTICS INC | 494K | $1M+ | SH |
| OCS | OCULIS HOLDING AG | 107K | $1M+ | SH |
| RVMD | REVOLUTION MEDICINES INC | 56K | $1M+ | SH |
| HLXB | HELIX ACQUISITION CORP II | 187K | $1M+ | SH |
| TERN | TERNS PHARMACEUTICALS INC | 464K | $1M+ | SH |
| SRZN | SURROZEN, INC. | 170K | $1M+ | SH |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 48K | $1M+ | SH |
| TSHA | TAYSHA GENE THERAPIES INC | 486K | $1M+ | SH |
| AKRO | AKERO THERAPEUTICS INC | 20K | $1M+ | SH |
| ZYME | ZYMEWORKS INC | 84K | $1M+ | SH |
| LQDA | LIQUIDIA CORPORATION | 76K | $500K+ | SH |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 24K | $500K+ | SH |
| VSTM | VERASTEM INC | 150K | $500K+ | SH |
| FULC | FULCRUM THERAPEUTICS INC | 60K | $100K–$500K | SH |
| UNCY | UNICYCIVE THERAPEUTICS INC | 63K | $100K–$500K | SH |
| RAPP | RAPPORT THERAPEUTICS INC | 20K | $100K–$500K | SH |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 45K | $50K–$100K | SH |
| NUVB.WS | NUVATION BIO INC -CW27 | 91K | $15K–$50K | SH |